Articles about Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Adeia (ADEA) Q3 2026 Earnings Call Transcript ↗

Today 23:28 EST

Via The Motley Fool

Motorcar Parts of America Sees $400M Centric Brand Opportunity After First Brands Bankruptcy ↗

Today 21:14 EST

Via MarketBeat

Donaldson Maps Growth Strategy, $830M Facet Deal and Margin Expansion ↗

Today 20:14 EST

Via MarketBeat

Adeia Q3 Earnings Call Highlights ↗

Today 19:14 EST

Via MarketBeat

Axis International Announces Marketing and Licensing Campaign for MiDefender, a Patented 5-in-1 Personal Safety Device

Today 15:36 EST

Via PRLog

AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test ↗

Today 13:15 EST

Via MarketBeat

International Business Machines vs. Synopsys: Which Technology Stock Is a Better Buy for 2027? ↗

Today 11:57 EST

Via The Motley Fool

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027? ↗

Today 11:20 EST

Via The Motley Fool

tZERO, a Leader in Tokenization Infrastructure, to Go Public Via Business Combination With FG Imperii Acquisition Corp.

Today 9:00 EST

Via NewMediaWire

Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo ↗

Today 5:45 EST

Via The Motley Fool

First Hydrogen Definitive Agreement with RoboticsCo Approved

Today 3:05 EST

Via Newsfile

First Solar: 3 Key Takeaways for Long-Term Investors ↗

November 01, 2026

Via The Motley Fool

Law Firm Extends Company Formation Support to International Founders

November 01, 2026

Via Press Advantage

AstraZeneca: 3 Key Takeaways for Long-Term Investors ↗

November 01, 2026

Via The Motley Fool

Ultrahuman Ring Pro promo code and gift guide: the smart ring back on sale in the US

November 01, 2026

Via AB Newswire

Looking For Growth, Income, and Stability? This Stock Could Offer All 3 ↗

October 31, 2026

Via The Motley Fool

AbbVie: 3 Key Takeaways for Long-Term Investors ↗

October 31, 2026

Via The Motley Fool

Is AbbVie a Buy After Its Latest Earnings Report? ↗

October 31, 2026

Via The Motley Fool

Pfizer Just Hit a 52-Week High. Is the Turnaround Finally Real? ↗

October 31, 2026

Via The Motley Fool

Why Merck Stock Flew Higher on Friday ↗

October 30, 2026

Via The Motley Fool

Why FMC Corporation Rallied Today ↗

October 30, 2026

Via The Motley Fool

Starz: 3 Key Takeaways for Long-Term Investors ↗

October 30, 2026

Via The Motley Fool

FSLR Q3 deep dive: bookings slowdown and pricing strength amid policy uncertainty

October 30, 2026

Via StockStory

BAINENG Opens Overseas Dealer Programme for Stainless Steel Cabinet Partners

October 30, 2026

Via PRLog

Dark Matter acquires House Numbers’ agentic AI platform for home lending, names Jeff Levinsohn chief AI officer

October 30, 2026

Via Send2Press

Oshkosh (OSK) Q3 2026 Earnings Call Transcript ↗

October 29, 2026

Via The Motley Fool

What Investors Look for in a Business Plan Before Investing

October 29, 2026

Via GlobePRwire

Bristol Myers’ Growth Drugs Hit $7.7 Billion: Rapid Earnings Reaction ↗

October 29, 2026

Via The Motley Fool

InterDigital Q3 Earnings Call Highlights ↗

October 29, 2026

Via MarketBeat

Merck Lifts Outlook on a Lower Tax Rate: Rapid Earnings Reaction ↗

October 29, 2026

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.